TCL Archive DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year February 27, 1987
TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive Four cancer centers form privately-funded Multiple Myeloma Research Consortium. Plan grew out of a recommendation to NCI, but organizers didn’t want to wait for the government to take action. September 10, 2004
TCL Archive FDA says official spoke on own behalf in admonition to The Cancer Letter. Association of Health Care Journalists asks FDA official to rescind her rebuke. March 18, 2005
